Structural requirements for C3d,g/Epstein-Barr virus receptor (CR2/CD21) ligand binding, internalization, and viral infection

被引：0
|
作者：
机构：
来源：
| 1600年 / American Society for Biochemistry and Molecular Biology Inc., Bethesda, United States卷 / 265期
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] ANALYSIS OF C3D/EPSTEIN-BARR VIRUS RECEPTOR (CR-2) EPITOPES BY DELETIONAL MUTAGENESIS
    HOLERS, VM
    CAREL, JC
    CLINICAL RESEARCH, 1989, 37 (02): : A412 - A412
  • [22] Evidence for a third transcript of the Epstein-Barrvirus/C3d receptor (Cr2, CD21) which is due to alternative exon usage
    Barel, M
    Balbo, M
    Frade, R
    MOLECULAR IMMUNOLOGY, 1998, 35 (6-7) : 350 - 350
  • [23] CD21 (Complement Receptor 2) Is the Receptor for Epstein-Barr Virus Entry into T Cells
    Smith, Nicholas A.
    Coleman, Carrie B.
    Gewurz, Benjamin E.
    Rochford, Rosemary
    JOURNAL OF VIROLOGY, 2020, 94 (11)
  • [24] Molecular Basis of the Interaction between Complement Receptor Type 2 (CR2/CD21) and Epstein-Barr Virus Glycoprotein gp350
    Young, Kendra A.
    Herbert, Andrew P.
    Barlow, Paul N.
    Holers, V. Michael
    Hannan, Jonathan P.
    JOURNAL OF VIROLOGY, 2008, 82 (22) : 11217 - 11227
  • [25] BIOCHEMICAL-STUDIES OF THE EPSTEIN-BARR VIRUS (EBV)/C3D (CR-2) RECEPTOR
    SIAW, MFE
    NEMEROW, GR
    COOPER, NR
    FEDERATION PROCEEDINGS, 1985, 44 (04) : 988 - 988
  • [26] Site-directed mutagenesis of human CR2/CD21 in conjunction with C3d
    Hannan, JP
    Young, KA
    Asokan, R
    Gerda, SI
    Chen, XJ
    Holers, VM
    FASEB JOURNAL, 2003, 17 (07): : C108 - C108
  • [27] INCORPORATION OF THE PURIFIED EPSTEIN-BARR VIRUS/C3D RECEPTOR (CR-2) INTO LIPOSOMES AND DEMONSTRATION OF ITS DUAL LIGAND-BINDING FUNCTIONS
    MOLD, C
    COOPER, NR
    NEMEROW, GR
    JOURNAL OF IMMUNOLOGY, 1986, 136 (11): : 4140 - 4145
  • [28] Human lymphocyte shed a soluble form of CD21 (the C3dg/Epstein-Barr virus receptor, CR2) that binds iC3b and CD23
    FremeauxBacchi, V
    Bernard, I
    Maillet, F
    Mani, JC
    Fontaine, M
    Bonnefoy, JY
    Kazatchkine, MD
    Fischer, E
    EUROPEAN JOURNAL OF IMMUNOLOGY, 1996, 26 (07) : 1497 - 1503
  • [29] Mutational analysis of the complement receptor type 2 (CR2/CD21)-C3d interaction reveals a putative charged SCR1 binding site for C3d
    Hannan, JP
    Young, KA
    Guthridge, JM
    Asokan, R
    Szakonyi, G
    Chen, XJS
    Holers, VM
    JOURNAL OF MOLECULAR BIOLOGY, 2005, 346 (03) : 845 - 858
  • [30] STUDIES OF THE EPSTEIN-BARR VIRUS RECEPTOR FOUND ON RAJI CELLS .2. A COMPARISON OF LYMPHOCYTE BINDING-SITES FOR EPSTEIN-BARR VIRUS AND C3D
    HUTTFLETCHER, LM
    FOWLER, E
    LAMBRIS, JD
    FEIGHNY, RJ
    SIMMONS, JG
    ROSS, GD
    JOURNAL OF IMMUNOLOGY, 1983, 130 (03): : 1309 - 1312
12345